迷宫制药 MAZE
$34.19 +$1.66 (+5.10%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $34.69 +1.46%
开盘$32.72
昨收$32.53
当日区间$32.42 – $35.00
成交量563.9K
市值$1.90B
市盈率（TTM）–
股息率–
MAZE 相关新闻
匹配 Maze Therapeutics 或代码 MAZE 的头条新闻，按最新排序。
- Citi Initiates Maze Therapeutics(MAZE.US) With Buy Rating, Announces Target Price $50
- HC Wainwright & Co. Reiterates Buy on Maze Therapeutics, Maintains $110 Price Target
- Wedbush Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Maintains Target Price $48
- Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) and Aytu BioScience (AYTU)
- Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE) and Ionis Pharmaceuticals (IONS)
- Analysts Are Bullish on Top Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) 正面
- A Quick Look at Today's Ratings for Maze Therapeutics(MAZE.US), With a Forecast Between $46 to $110
- Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Maze Therapeutics, Inc. (MAZE) 正面
- Analysts Are Bullish on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Mirum Pharmaceuticals (MIRM) 正面
- Wells Fargo Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Maintains Target Price $55
- Truist Financial Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Announces Target Price $64
- A Quick Look at Today's Ratings for Maze Therapeutics(MAZE.US), With a Forecast Between $48 to $110
- Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT)
- Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)
- H.C. Wainwright Maintains Maze Therapeutics(MAZE.US) With Buy Rating, Maintains Target Price $110
暂无评论——快来第一个聊聊 MAZE。
登录后参与讨论。